Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2020-09-30 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Tiziana Life Sciences plc, with the SEC. It references an attached Regulatory News Service (RNS) Announcement dated September 30, 2020, which announces the Interim Results for the six months ended June 30, 2020. The document itself is short (2934 characters) and primarily serves to furnish the RNS announcement rather than containing the full interim financial report. According to the 'Menu vs Meal' rule, such a document that states a report is attached or furnished but does not contain substantive financial data itself should be classified as a Regulatory Filing (RNS).
2020-09-30 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement attached as Exhibit 99.1. The text states that the information is being furnished and not filed, and it is an announcement of an interview airing on Bloomberg, not a financial report or detailed filing. The document length is short (2830 characters), and it primarily serves as a regulatory filing to disclose the RNS announcement. There is no substantive financial data or detailed report content. Therefore, this document fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure.
2020-09-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement dated September 21, 2020, and explicitly states that the information is furnished and not filed, indicating it is an announcement rather than a full report. The document length is short (2907 characters), and it mainly serves to provide the RNS announcement as an exhibit. There is no substantive financial data or detailed report content within this document itself. According to the rules, such documents that announce or furnish reports without containing the full report content should be classified as Regulatory Filings (RNS).
2020-09-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) Announcement regarding the Issue of Equity and Total Voting Rights. The document itself is short (2948 characters) and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. It explicitly states that the attached RNS Announcement is being furnished and is not deemed filed for certain regulatory purposes. This aligns with the characteristics of a Regulatory Filing (RNS) as a general regulatory announcement and compliance document. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-09-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about a clinical study for COVID-19 treatment. The document is relatively short (3136 characters) and primarily serves to furnish an announcement rather than provide detailed financial data or a full report. It explicitly states that the attached announcement is furnished and not filed for certain regulatory purposes. This aligns with the characteristics of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for filings that do not fit other specific categories. There is no detailed financial data, management discussion, or other report content that would classify it as an Annual Report, Interim Report, or other specific report types. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-09-17 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains an announcement about the company's plan to demerge an asset into a separate listed company, referencing an attached announcement and a demerger circular. The document is relatively short (2992 characters) and primarily serves to furnish information rather than provide detailed financial data or a full report. It does not contain comprehensive financial statements or detailed analysis. The nature of the content is an announcement of a corporate action (demerger) rather than the full demerger circular or detailed report itself. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into more specific categories like M&A filings or capital updates, and it is not a full report or presentation.
2020-09-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.